Nuvalent, Inc. (NUVL)
NASDAQ: NUVL · Real-Time Price · USD
109.04
+3.11 (2.94%)
At close: Jan 21, 2026, 4:00 PM EST
110.00
+0.96 (0.88%)
After-hours: Jan 21, 2026, 5:56 PM EST
Nuvalent Market Cap
Nuvalent has a market cap or net worth of $8.47 billion as of January 21, 2026. Its market cap has increased by 48.99% in one year.
Market Cap
8.47B
Enterprise Value
7.52B
1-Year Change
48.99%
Ranking
Category
Stock Price
$109.04
Market Cap Chart
Since the IPO on July 29, 2021, Nuvalent's market cap has increased from $795.96M to $8.47B, an increase of 963.83%. That is a compound annual growth rate of 69.47%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 20, 2026 | 8.23B | 5.31% |
| Dec 31, 2025 | 7.81B | 40.44% |
| Dec 31, 2024 | 5.56B | 20.68% |
| Dec 29, 2023 | 4.61B | 174.21% |
| Dec 30, 2022 | 1.68B | 82.83% |
| Dec 31, 2021 | 919.33M | 15.50% |
| Jul 29, 2021 | 795.96M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Jazz Pharmaceuticals | 10.28B |
| Axsome Therapeutics | 9.53B |
| ABIVAX Société Anonyme | 9.34B |
| Arrowhead Pharmaceuticals | 9.29B |
| Praxis Precision Medicines | 8.67B |
| Halozyme Therapeutics | 8.43B |
| Krystal Biotech | 8.29B |
| Cytokinetics | 7.71B |